Joincare Gross Profit from 2010 to 2024

600380 Stock   11.12  0.05  0.45%   
Joincare Pharmaceutical's Gross Profit is increasing over the years with slightly volatile fluctuation. Gross Profit is expected to dwindle to about 8.9 B. Gross Profit is the profit Joincare Pharmaceutical Group makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals
 
Gross Profit  
First Reported
2002-03-31
Previous Quarter
2.5 B
Current Value
2.3 B
Quarterly Volatility
872.5 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Joincare Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Joincare Pharmaceutical's main balance sheet or income statement drivers, such as Interest Expense of 154.1 M, Selling General Administrative of 2.7 B or Total Revenue of 17.5 B, as well as many indicators such as . Joincare financial statements analysis is a perfect complement when working with Joincare Pharmaceutical Valuation or Volatility modules.
  
This module can also supplement various Joincare Pharmaceutical Technical models . Check out the analysis of Joincare Pharmaceutical Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Joincare Stock

Joincare Pharmaceutical financial ratios help investors to determine whether Joincare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Joincare with respect to the benefits of owning Joincare Pharmaceutical security.